We are live on ! Find out more
CCMU

Cheyne Capital Management (UK) Portfolio holdings

AUM $27.9M
1-Year Est. Return 36.14%
This Fund
S&P 500
This Quarter Est. Return
+3.61%
1 Year Est. Return
+36.14%
3 Year Est. Return
+35.61%
5 Year Est. Return
+211.68%
10 Year Est. Return
+661.99%
AUM
$140M
AUM Growth
-$80.9M
Cap. Flow
-$187M
Cap. Flow %
-133.21%
Top 10 Hldgs %
51.73%
Holding
43
New
2
Increased
2
Reduced
1
Closed
9

Top Buys

Rank Stock Value
1
CVNA icon
Carvana
CVNA
+$4.95M
2
GTT
GTT Communications, Inc.
GTT
+$4.51M
3
T icon
AT&T
T
+$1.36M
4
RDNT icon
RadNet
RDNT
+$69.3K

Sector Composition

Rank Sector Weight
1 Healthcare 5.47%
2 Consumer Discretionary 4.88%
3 Communication Services 4.84%
4 Financials 1.98%
5 Materials 0.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVNA icon
1
Carvana
CVNA
$67.5B
$6.84M 4.88%
+822,500
New +$4.95M
GTT
2
DELISTED
GTT Communications, Inc.
GTT
$5.48M 3.9%
121,800
+90,562
+290% +$4.51M
RDNT icon
3
RadNet
RDNT
$5.04B
$5.27M 3.76%
351,393
+5,100
+1% +$69.3K
APO icon
4
Apollo Global Management
APO
$71.7B
$2.79M 1.98%
87,418
T icon
5
AT&T
T
$159B
$1.32M 0.94%
+54,284
New +$1.36M
ZGNX
6
DELISTED
Zogenix, Inc.
ZGNX
$972K 0.69%
22,000
-22,500
-51% -$927K
VNDA icon
7
Vanda Pharmaceuticals
VNDA
$305M
$781K 0.56%
41,000
BCRX icon
8
BioCryst Pharmaceuticals
BCRX
$2.28B
$573K 0.41%
100,000
B
9
Barrick Mining
B
$61.5B
$328K 0.23%
25,000
SGYP
10
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$87K 0.06%
50,000
PPLI
11
People Inc
PPLI
$3.07B
-756,454
Closed -$21.1M
IBB icon
12
iShares Biotechnology ETF
IBB
$9.34B
-64,300
Closed -$6.86M
W icon
13
Wayfair
W
$11.4B
-37,300
Closed -$2.52M
DISCK
14
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
-840,337
Closed -$16.4M
AKRX
15
DELISTED
Akorn Inc
AKRX
-200,000
Closed -$3.74M
COL
16
DELISTED
Rockwell Collins
COL
-122,499
Closed -$16.6M
TWX
17
DELISTED
Time Warner Inc
TWX
-252,013
Closed -$23.9M
MON
18
DELISTED
Monsanto Co
MON
-268,817
Closed -$31.4M
TRCO
19
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
-515,731
Closed -$20.9M

Similar funds

Cheyne Capital Management (UK)'s Q2 2018 Portfolio in Review

As of Q2 2018, Cheyne Capital Management (UK) held 43 positions worth $140M, down 37% from $221M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Cheyne Capital Management (UK) withdrew a net $187M in Q2 2018, closing 9 positions and reducing 1 holding. Its most notable exit was Monsanto Co, an estimated $31.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 5.5% of assets, up from 3.6% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Cheyne Capital Management (UK) opened a new position in Carvana worth $6.84M.

  • Cheyne Capital Management (UK)'s largest Q2 2018 buy was Carvana: 822,500 shares worth $6.84M.
  • Cheyne Capital Management (UK) added most to GTT Communications, Inc. in Q2 2018, an estimated $4.51M increase.
  • Cheyne Capital Management (UK)'s biggest Q2 2018 reduction was Zogenix, Inc., cutting an estimated $927K.
  • Cheyne Capital Management (UK) fully exited Monsanto Co in Q2 2018, selling an estimated $31.4M.
  • Cheyne Capital Management (UK)'s ten largest holdings make up 52% of its $140M portfolio in Q2 2018.
  • Cheyne Capital Management (UK) opened 2 new positions and closed 9 in Q2 2018.
  • Cheyne Capital Management (UK)'s portfolio value fell 37% quarter-over-quarter to $140M.

Based on Cheyne Capital Management (UK)'s 13F filing for Q2 2018, filed 2 Aug 2018.